glp 1 alzheimer's 🧠 Researchers are exploring whether GLP-1 medications used for #diabetes and weight loss could treat #Alzheimers and addiction, but public concerns persist about long-term safety. 🔗 Read the full article at beingpatient.com # GLP-1 Receptor Agonists in Neurodegeneration:

A total of 448 patients received at least one dose of protocol-specified therapy

Gut microbiota metabolism of L-carnitine and cardiovascular risk

Protocol 4: degenerative disc disease and facet arthritis (advanced) Goal: Slow degenerative processes and support tissue quality in chronic spinal degeneration Peptides: BPC-157 : 500mcg twice daily ongoing GHK-Cu : 2mg daily for tissue regeneration KPV : 300mcg daily for anti-inflammatory effects Optional : TB-500 2mg weekly for systemic support Duration: Extended protocols, potentially cycling on and off Why this works: Degenerative conditions require ongoing support rather than acute treatment

In addition, you dont want to risk losing your medication if your checked bag is delayed or lost

Serum levels of 25-hydroxyvitamin D3 negatively correlate with endometriosis (124)